Go to main content
United Kingdom

Product Details

Esmolol® is indicated for supraventricular tachycardia and for the rapid control of the ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short-acting agent is desirable.

Amomed Pharma GmbH is the MA-Holder and AOP Health has the distribution rights.

Please use the emc links below to download PIL:

Esmolol 2,500mg Powder:


Esmolol 10mg/ml solution:


Drug Facts

Active ingredient

Esmolol Hydrochloride